← FDA Drug Approvals (Drugs@FDA)

TRAVOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2017-07-07

Drug application

FDA Application #
ANDA205050
Application type
Abbreviated New Drug Application (Generic)
Brand name
TRAVOPROST
Generic name
TRAVOPROST OPHTHALMIC SOLUTION, 0.004%
Active ingredients
TRAVOPROST
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Prescription
Sponsor
MYLAN
Manufacturer
Mylan Pharmaceuticals Inc.
First approval
2017-07-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown